BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 23, 2013
View Archived Issues
Subcutaneous grass pollen monomeric carbamylated allergoid tested in allergic rhinoconjunctivitis
Read More
Changes in FXIII observed in patients with myocardial infarction
Read More
Matrix metalloproteinase-10 levels increased in patients with peripheral artery disease
Read More
New ACC-beta inhibitors synthesized by Boehringer Ingelheim
Read More
Ironwood Pharmaceuticals prepares new sGC activators
Read More
BioDiem's liver disease vaccine program achieves proof of principle
Read More
Roche launches Elecsys ProGRP test to diagnose small cell lung cancer
Read More
Medigen Biotechnology provides update on phase III PATRON trial
Read More
BioCryst completes phase I trial of BCX-4161
Read More
Xoma provides update on development program for gevokizumab
Read More
Bio-Path begins development of liposomal GRB2 for two breast cancer indications
Read More
Merrimack begins patient enrollment in phase II trial in advanced gastroesophageal cancers
Read More
MBio Diagnostics receives NIH grant to continue development of POC HIV diagnostic device
Read More
Researchers disclose new agents for sickle cell disease and other disorders
Read More
Agios Pharmaceuticals divulges new IDH2 inhibitors for cancer
Read More
Spinifex Pharmaceuticals synthesizes novel AT2 receptor antagonists
Read More
Alzheimer's disease vaccine vanutide evaluated in Japanese patients in phase II study
Read More
Janssen R&D patents novel agents for HBV infection
Read More
AB Science receives funding to develop therapy for Alzheimer's disease
Read More
Galapagos earns milestone in osteoarthritis alliance with Servier
Read More
New sodium channel blockers presented by Pfizer
Read More
Phase II data reported for BMS-927711 in migraine
Read More
Prana completes phase II trial of lead candidate in Huntington's disease
Read More
Atterocor commences first-in-human trial of ATR-101 in advanced adrenocortical carcinoma
Read More